Chu-Liang Lin Selected Research

Chu-Liang Lin Research Topics

9	Neoplasms (Cancer) 04/2024 - 10/2015
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2023 - 10/2015
3	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2016
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 10/2017
2	Prostatic Neoplasms (Prostate Cancer) 10/2017 - 02/2017
1	Osteosarcoma (Osteogenic Sarcoma) 04/2024
1	Endometrial Neoplasms (Endometrial Cancer) 02/2024
1	Kidney Neoplasms (Kidney Cancer) 01/2018
1	Inflammation (Inflammations) 01/2016

2	licochalcone AIBA 02/2024 - 10/2015
2	norcantharidinIBA 01/2018 - 10/2017
2	Matrix Metalloproteinases (MMPs)IBA 02/2017 - 10/2015
1	AntioxidantsIBA 04/2024
1	TriterpenesIBA 04/2024
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 04/2024
1	WortmanninIBA 04/2024
1	asiatic acidIBA 04/2024
1	Endoplasmic Reticulum Chaperone BiPIBA 02/2024
1	Butyric Acid (Butanoic Acid)IBA 12/2023
1	Interleukin-10 ReceptorsIBA 12/2023
1	magnolinIBA 12/2023
1	Annexin A5IBA 01/2018
1	CaspasesIBA 10/2017
1	Cantharidin (Cantharides)IBA 10/2017
1	Proteins (Proteins, Gene)FDA Link 02/2017
1	Cyclin D1IBA 02/2017
1	Sorafenib (BAY 43-9006)FDA Link 05/2016
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 05/2016
1	fisetinIBA 05/2016
1	Antineoplastic Agents (Antineoplastics)IBA 05/2016
1	Caspase 8 (Caspase-8)IBA 05/2016
1	Caspase 3 (Caspase-3)IBA 05/2016
1	FlavonoidsIBA 05/2016
1	Cyclin B1IBA 01/2016
1	PTX3 proteinIBA 01/2016
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2016
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Small Interfering RNA (siRNA)IBA 01/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2015
1	Dihydrotachysterol (AT 10)IBA 10/2015

1	Drug Therapy (Chemotherapy) 05/2016
1	Chemoprevention 10/2015